The global respiratory inhalers market is estimated to be valued at US$ 35 Bn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Respiratory inhalers are a well-established treatment for asthma and COPD. They provide quick relief and are...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian